Fig. 2From: BIRC3 and BIRC5: multi‐faceted inhibitors in cancerSMAC mimetics activity on cIAPs. SMAC mimetics bind to BIR3 domains and induce homo-dimerization. Ubiquitin is recruited and leads to cIAP degradationBack to article page